Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer
Tao Lu, Jai Prakash Engineered Therapeutics Group, Department of Biomaterials Science and Technology, University of Twente, Enschede, The NetherlandsCorrespondence: Jai PrakashEngineered Therapeutics, Department of Biomaterials Science and Technology, University of Twente, Drienerlolaan 5, Enschede,...
Guardado en:
Autores principales: | Lu T, Prakash J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/016ad452d5cc4d7e982d295a6d6df70b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
por: Parniyan Maneshi, et al.
Publicado: (2021) -
Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology
por: Alin Mihai Vasilescu, et al.
Publicado: (2021) -
Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review
por: Hong-Bo Li, et al.
Publicado: (2021) -
Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
por: Paula Marie Schmidtlein, et al.
Publicado: (2021) -
Size-Adjustable Nano-Drug Delivery Systems for Enhanced Tumor Retention and Penetration
por: Miao Deng, et al.
Publicado: (2021)